CAO Wei. Progress in Bone Marrow-targeting Nanoparticles[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(10): 231-235.
DOI:
CAO Wei. Progress in Bone Marrow-targeting Nanoparticles[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(10): 231-235. DOI: 10.13422/j.cnki.syfjx.2015100231.
Bone marrow is an important hematopoietic and immune organ. It contains hematopoiesis stem cells
mesenchymal stem cells
stromal cells
which provide a specific microenvironment with various growth factors and chemotactic factors. However
it causes the primary obstacle of successful eradication of bone marrow-associated diseases. Under the pathological condition
the bone marrow microenvironment supports the metastasis and growth of malignant cells. In addition
the delivery of therapeutic drugs has been hampered by its unique anatomical structure and bone marrow blood barrier. With the progress on the study on the bone marrow microenvironment and the mechanism of the particle uptake from the blood circulation
macrophage and E-selectin receptor on endothelial cells have been discovered as targets for improving the bone marrow-targeting ability of drugs used for therapy. Combined with nanoparticles technology
passive or active bone marrow-targeting ability of drugs are further improving by controlling the size or modifying the surface of nanoparticles. Herein
the physiological structure and biologic functions of bone marrow are analyzed
and the bone marrow targeting nanoparticles including liposomes and polymer micelles are summarized
which provides the favorable methods for the diagnosis and therapy of bone marrow-related diseases.